Skip to main content
Erschienen in: Cardiovascular Toxicology 2/2022

18.11.2021

Using Machine Learning Approaches to Predict Short-Term Risk of Cardiotoxicity Among Patients with Colorectal Cancer After Starting Fluoropyrimidine-Based Chemotherapy

verfasst von: Chao Li, Li Chen, Chiahung Chou, Surachat Ngorsuraches, Jingjing Qian

Erschienen in: Cardiovascular Toxicology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Cardiotoxicity is a severe side effect for colorectal cancer (CRC) patients undergoing fluoropyrimidine-based chemotherapy. To develop and compare machine learning algorithms to predict cardiotoxicity risk among nationally representative CRC patients receiving fluoropyrimidine, CRC Patients with at least one claim of fluoropyrimidine after their cancer diagnosis were included. The outcome was the 30-day cardiotoxicity from the first day of starting fluoropyrimidine. The machine learning models including extreme gradient boosting (XGBoost), random forest (RF), and logistic regression (LR) were developed using 2006–2011 SEER-Medicare data, and model performances were evaluated using 2012–2014 data. Precision, F1 score, and area under the receiver operating characteristics curve (AUC) were measured to evaluate model performances. Feature importance plots were obtained to quantify the predictor importance. Among 36,030 CRC patients, 18.74% of them developed cardiotoxicity within 30 days since the first fluoropyrimidine. The XGBoost approach had better prediction performance with higher precision (0.619) and F1 score (0.406) in predicting the 30-day cardiotoxicity, compared to the RF (precision, 0.607 and F1 score, 0.395) and LR (precision, 0.610 and F1 score, 0.398). According to the DeLong’s test for AUC difference, the XGBoost significantly outperformed the RF and LR (XGBoost, 0.816 vs. RF, 0.804, P < 0.001; XGBoost vs. LR, 0.812, P = 0.003, respectively). Feature importance plots identified pre-existing cardiac conditions, surgery, older age as top significant risk factors for cardiotoxicity events among CRC patients after receiving fluoropyrimidine. In summary, the developed machine learning models can accurately predict the occurrence of 30-day cardiotoxicity among CRC patients receiving fluoropyrimidine-based chemotherapy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-fluorouracil: Mechanisms of action and clinical strategies. Nature Reviews Cancer, 3, 330–338. CrossRef Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-fluorouracil: Mechanisms of action and clinical strategies. Nature Reviews Cancer, 3, 330–338. CrossRef
3.
Zurück zum Zitat Jin, X., Bai, Y., Gao, L., & Wu, S. (2019). Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients. Cancer Chemotherapy and Pharmacology, 84, 599–607. CrossRef Jin, X., Bai, Y., Gao, L., & Wu, S. (2019). Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients. Cancer Chemotherapy and Pharmacology, 84, 599–607. CrossRef
4.
Zurück zum Zitat Khan, M. A., Masood, N., Husain, N., Ahmad, B., Aziz, T., & Naeem, A. (2012). A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center. The Journal of the Pakistan Medical Association, 62, 430–434. PubMed Khan, M. A., Masood, N., Husain, N., Ahmad, B., Aziz, T., & Naeem, A. (2012). A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center. The Journal of the Pakistan Medical Association, 62, 430–434. PubMed
6.
Zurück zum Zitat Abdel-Rahman, O. (2019). 5-Fluorouracil-related cardiotoxicity; findings from five randomized studies of 5-fluorouracil-based regimens in metastatic colorectal cancer. Clinical Colorectal Cancer, 18, 58–63. CrossRef Abdel-Rahman, O. (2019). 5-Fluorouracil-related cardiotoxicity; findings from five randomized studies of 5-fluorouracil-based regimens in metastatic colorectal cancer. Clinical Colorectal Cancer, 18, 58–63. CrossRef
7.
Zurück zum Zitat Kosmas, C., Kallistratos, M. S., Kopterides, P., Syrios, J., Skopelitis, H., Mylonakis, N., et al. (2008). Cardiotoxicity of fluoropyrimidines in different schedules of administration: A prospective study. Journal of Cancer Research and Clinical Oncology, 134, 75–82. CrossRef Kosmas, C., Kallistratos, M. S., Kopterides, P., Syrios, J., Skopelitis, H., Mylonakis, N., et al. (2008). Cardiotoxicity of fluoropyrimidines in different schedules of administration: A prospective study. Journal of Cancer Research and Clinical Oncology, 134, 75–82. CrossRef
8.
Zurück zum Zitat Kwakman, J. J. M., Simkens, L. H. J., Mol, L., Kok, W. E. M., Koopman, M., & Punt, C. J. A. (2017). Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group. European Journal of Cancer, 76, 93–99. CrossRef Kwakman, J. J. M., Simkens, L. H. J., Mol, L., Kok, W. E. M., Koopman, M., & Punt, C. J. A. (2017). Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group. European Journal of Cancer, 76, 93–99. CrossRef
9.
Zurück zum Zitat Stewart, T., Pavlakis, N., & Ward, M. (2010). Cardiotoxicity with 5-fluorouracil and capecitabine: More than just vasospastic angina. Internal Medicine Journal, 40, 303–307. CrossRef Stewart, T., Pavlakis, N., & Ward, M. (2010). Cardiotoxicity with 5-fluorouracil and capecitabine: More than just vasospastic angina. Internal Medicine Journal, 40, 303–307. CrossRef
10.
Zurück zum Zitat NCCN. (2019) Colon Cancer. NCCN Clinical Practice Guidelines in Oncology. 181. NCCN. (2019) Colon Cancer. NCCN Clinical Practice Guidelines in Oncology. 181.
11.
Zurück zum Zitat NCCN. (2019) Rectal Cancer. NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer. 166 NCCN. (2019) Rectal Cancer. NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer. 166
12.
Zurück zum Zitat Churpek, M. M., Yuen, T. C., Winslow, C., Meltzer, D. O., Kattan, M. W., & Edelson, D. P. (2016). Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Critical Care Medicine, 44, 368–374. CrossRef Churpek, M. M., Yuen, T. C., Winslow, C., Meltzer, D. O., Kattan, M. W., & Edelson, D. P. (2016). Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Critical Care Medicine, 44, 368–374. CrossRef
14.
Zurück zum Zitat Van Belle, V. M. C. A., Van Calster, B., Timmerman, D., Bourne, T., Bottomley, C., Valentin, L., et al. (2012). A mathematical model for interpretable clinical decision support with applications in gynecology. PLoS ONE, 7, e34312. CrossRef Van Belle, V. M. C. A., Van Calster, B., Timmerman, D., Bourne, T., Bottomley, C., Valentin, L., et al. (2012). A mathematical model for interpretable clinical decision support with applications in gynecology. PLoS ONE, 7, e34312. CrossRef
15.
Zurück zum Zitat Brick, T. R., Koffer, R. E., Gerstorf, D., & Ram, N. (2018). Feature selection methods for optimal design of studies for developmental inquiry. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 73, 113–123. CrossRef Brick, T. R., Koffer, R. E., Gerstorf, D., & Ram, N. (2018). Feature selection methods for optimal design of studies for developmental inquiry. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 73, 113–123. CrossRef
16.
Zurück zum Zitat Lu, H., Gao, H., Ye, M., Wang, X. (2019). A hybrid ensemble algorithm combining adaboost and genetic algorithm for cancer classification with gene expression data. IEEE/ACM Transactions on Computational Biology and Bioinformatics Lu, H., Gao, H., Ye, M., Wang, X. (2019). A hybrid ensemble algorithm combining adaboost and genetic algorithm for cancer classification with gene expression data. IEEE/ACM Transactions on Computational Biology and Bioinformatics
18.
Zurück zum Zitat Hosni, M., Abnane, I., Idri, A., Carrillo de Gea, J. M., & Fernández Alemán, J. L. (2019). Reviewing ensemble classification methods in breast cancer. Computers Methods and Programs in Biomedicine, 177, 89–112. CrossRef Hosni, M., Abnane, I., Idri, A., Carrillo de Gea, J. M., & Fernández Alemán, J. L. (2019). Reviewing ensemble classification methods in breast cancer. Computers Methods and Programs in Biomedicine, 177, 89–112. CrossRef
19.
Zurück zum Zitat Enewold, L., Parsons, H., Zhao, L., Bott, D., Rivera, D. R., Barrett, M. J., et al. (2020). Updated overview of the SEER-medicare data: enhanced content and applications. JNCI Monographs, 2020, 3–13. Enewold, L., Parsons, H., Zhao, L., Bott, D., Rivera, D. R., Barrett, M. J., et al. (2020). Updated overview of the SEER-medicare data: enhanced content and applications. JNCI Monographs, 2020, 3–13.
20.
Zurück zum Zitat Chen, J., Long, J. B., Hurria, A., Owusu, C., Steingart, R. M., & Gross, C. P. (2012). Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. Journal of the American College of Cardiology., 60, 2504–2512. CrossRef Chen, J., Long, J. B., Hurria, A., Owusu, C., Steingart, R. M., & Gross, C. P. (2012). Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. Journal of the American College of Cardiology., 60, 2504–2512. CrossRef
21.
Zurück zum Zitat Kenzik, K. M., Balentine, C., Richman, J., Kilgore, M., Bhatia, S., & Williams, G. R. (2018). New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. JCO., 36, 609–616. CrossRef Kenzik, K. M., Balentine, C., Richman, J., Kilgore, M., Bhatia, S., & Williams, G. R. (2018). New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. JCO., 36, 609–616. CrossRef
22.
Zurück zum Zitat Hershman, D. L., McBride, R. B., Eisenberger, A., Tsai, W. Y., Grann, V. R., & Jacobson, J. S. (2008). Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin’s lymphoma. JCO., 26, 3159–3165. CrossRef Hershman, D. L., McBride, R. B., Eisenberger, A., Tsai, W. Y., Grann, V. R., & Jacobson, J. S. (2008). Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin’s lymphoma. JCO., 26, 3159–3165. CrossRef
23.
Zurück zum Zitat Ko, C. W., Dominitz, J. A., Neradilek, M., Polissar, N., Green, P., Kreuter, W., et al. (2014). Determination of colonoscopy indication from administrative claims data. Medical Care, 52, e21–e29. CrossRef Ko, C. W., Dominitz, J. A., Neradilek, M., Polissar, N., Green, P., Kreuter, W., et al. (2014). Determination of colonoscopy indication from administrative claims data. Medical Care, 52, e21–e29. CrossRef
25.
Zurück zum Zitat Silber, J. H., Rosenbaum, P. R., Clark, A. S., Giantonio, B. J., Ross, R. N., Teng, Y., et al. (2013). Characteristics associated with differences in survival among black and white women with breast cancer. JAMA, 310, 389–397. CrossRef Silber, J. H., Rosenbaum, P. R., Clark, A. S., Giantonio, B. J., Ross, R. N., Teng, Y., et al. (2013). Characteristics associated with differences in survival among black and white women with breast cancer. JAMA, 310, 389–397. CrossRef
26.
Zurück zum Zitat Edge, S. B., Compton, C. C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 17, 1471–1474. Edge, S. B., Compton, C. C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 17, 1471–1474.
27.
Zurück zum Zitat Bach, P. B., Guadagnoli, E., Schrag, D., Schussler, N., & Warren, J. L. (2002). Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Medical Care., 40, 19–25. CrossRef Bach, P. B., Guadagnoli, E., Schrag, D., Schussler, N., & Warren, J. L. (2002). Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Medical Care., 40, 19–25. CrossRef
28.
Zurück zum Zitat Chamie, K., Williams, S. B., & Hu, J. C. (2015). Population-based assessment of determining treatments for prostate cancer. JAMA Oncology, 1, 60. CrossRef Chamie, K., Williams, S. B., & Hu, J. C. (2015). Population-based assessment of determining treatments for prostate cancer. JAMA Oncology, 1, 60. CrossRef
29.
Zurück zum Zitat Zou, K. H., James, O. A., & Laura, M. (2007). Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation, 115, 654–657. CrossRef Zou, K. H., James, O. A., & Laura, M. (2007). Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation, 115, 654–657. CrossRef
30.
Zurück zum Zitat DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 44, 837–845. CrossRef DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 44, 837–845. CrossRef
31.
Zurück zum Zitat Weng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017). Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLOS One, 12, e0174944. CrossRef Weng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017). Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLOS One, 12, e0174944. CrossRef
32.
Zurück zum Zitat Parikh, R. B., Manz, C., Chivers, C., Regli, S. H., Braun, J., Draugelis, M. E., et al. (2019). Machine learning approaches to predict 6-month mortality among patients with cancer. JAMA Netw Open., 2, e1915997. CrossRef Parikh, R. B., Manz, C., Chivers, C., Regli, S. H., Braun, J., Draugelis, M. E., et al. (2019). Machine learning approaches to predict 6-month mortality among patients with cancer. JAMA Netw Open., 2, e1915997. CrossRef
33.
Zurück zum Zitat Wittayanukorn, S., Qian, J., Westrick, S. C., Billor, N., Johnson, B., & Hansen, R. A. (2018). Prevention of trastuzumab and anthracycline-induced cardiotoxicity using angiotensin-converting enzyme inhibitors or β-blockers in older adults with breast cancer. American Journal of Clinical Oncology, 41, 909–918. CrossRef Wittayanukorn, S., Qian, J., Westrick, S. C., Billor, N., Johnson, B., & Hansen, R. A. (2018). Prevention of trastuzumab and anthracycline-induced cardiotoxicity using angiotensin-converting enzyme inhibitors or β-blockers in older adults with breast cancer. American Journal of Clinical Oncology, 41, 909–918. CrossRef
34.
Zurück zum Zitat Polk, A., Vaage-Nilsen, M., Vistisen, K., & Nielsen, D. L. (2013). Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors. Cancer Treatment Reviews., 39, 974–984. CrossRef Polk, A., Vaage-Nilsen, M., Vistisen, K., & Nielsen, D. L. (2013). Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors. Cancer Treatment Reviews., 39, 974–984. CrossRef
35.
Zurück zum Zitat Li, C., Ngorsuraches, S., Chou, C., Chen, L., & Qian, J. (2021). Risk factors of fluoropyrimidine induced cardiotoxicity among cancer patients: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology., 162, 103346. CrossRef Li, C., Ngorsuraches, S., Chou, C., Chen, L., & Qian, J. (2021). Risk factors of fluoropyrimidine induced cardiotoxicity among cancer patients: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology., 162, 103346. CrossRef
36.
Zurück zum Zitat Smilowitz, N. R., & Berger, J. S. (2020). Perioperative cardiovascular risk assessment and management for noncardiac surgery: A review. JAMA, 324, 279–290. CrossRef Smilowitz, N. R., & Berger, J. S. (2020). Perioperative cardiovascular risk assessment and management for noncardiac surgery: A review. JAMA, 324, 279–290. CrossRef
37.
Zurück zum Zitat Raslau, D., Bierle, D. M., Stephenson, C. R., Mikhail, M. A., Kebede, E. B., & Mauck, K. F. (2020). Preoperative cardiac risk assessment. Mayo Clinic Proceedings, 95, 1064–1079. CrossRef Raslau, D., Bierle, D. M., Stephenson, C. R., Mikhail, M. A., Kebede, E. B., & Mauck, K. F. (2020). Preoperative cardiac risk assessment. Mayo Clinic Proceedings, 95, 1064–1079. CrossRef
38.
Zurück zum Zitat Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. American Heart Association, 140, e596-646. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., et al. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation. American Heart Association, 140, e596-646.
40.
Zurück zum Zitat Blanter, J. B., & Frishman, W. H. (2019). The preventive role of angiotensin converting enzyme inhibitors/angiotensin-II receptor blockers and β-adrenergic blockers in anthracycline- and trastuzumab-induced cardiotoxicity. Cardiology in Review, 27, 256–259. CrossRef Blanter, J. B., & Frishman, W. H. (2019). The preventive role of angiotensin converting enzyme inhibitors/angiotensin-II receptor blockers and β-adrenergic blockers in anthracycline- and trastuzumab-induced cardiotoxicity. Cardiology in Review, 27, 256–259. CrossRef
41.
Zurück zum Zitat Ezekowitz, M. D., & Falk, R. H. (2004). The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clinic Proceedings, 79, 904–913. CrossRef Ezekowitz, M. D., & Falk, R. H. (2004). The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clinic Proceedings, 79, 904–913. CrossRef
42.
Zurück zum Zitat Chan, N. C., & Eikelboom, J. W. (2019). How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism. Blood, 133, 2269–2278. CrossRef Chan, N. C., & Eikelboom, J. W. (2019). How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism. Blood, 133, 2269–2278. CrossRef
43.
Zurück zum Zitat Hu, C.-A., Chen, C.-M., Fang, Y.-C., Liang, S.-J., Wang, H.-C., Fang, W.-F., et al. (2020). Using a machine learning approach to predict mortality in critically ill influenza patients: a cross-sectional retrospective multicentre study in Taiwan. BMJ Open, 10, e033898. CrossRef Hu, C.-A., Chen, C.-M., Fang, Y.-C., Liang, S.-J., Wang, H.-C., Fang, W.-F., et al. (2020). Using a machine learning approach to predict mortality in critically ill influenza patients: a cross-sectional retrospective multicentre study in Taiwan. BMJ Open, 10, e033898. CrossRef
44.
Zurück zum Zitat Elfiky, A. A., Pany, M. J., Parikh, R. B., & Obermeyer, Z. (2018). Development and application of a machine learning approach to assess short-term mortality risk among patients with cancer starting chemotherapy. JAMA Netw Open., 1, e180926. CrossRef Elfiky, A. A., Pany, M. J., Parikh, R. B., & Obermeyer, Z. (2018). Development and application of a machine learning approach to assess short-term mortality risk among patients with cancer starting chemotherapy. JAMA Netw Open., 1, e180926. CrossRef
Metadaten
Titel
Using Machine Learning Approaches to Predict Short-Term Risk of Cardiotoxicity Among Patients with Colorectal Cancer After Starting Fluoropyrimidine-Based Chemotherapy
verfasst von
Chao Li
Li Chen
Chiahung Chou
Surachat Ngorsuraches
Jingjing Qian
Publikationsdatum
18.11.2021
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 2/2022
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-021-09708-4

Weitere Artikel der Ausgabe 2/2022

Cardiovascular Toxicology 2/2022 Zur Ausgabe